Sipuleucel-T: APC 8015, APC-8015, Prostate Cancer Vaccine – Dendreon

ISSN： 1174-5886

Source： Drugs in R&D, Vol.7, Iss.3, 2006-01, pp. : 197-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

APC 8015 may improve survival duration in prostate cancer

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sipuleucel-T extends survival in metastatic prostate cancer

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Sipuleucel-T [Provenge] prolongs prostate-specific antigen (PSA) doubling time in patients with androgen-dependent prostate cancer

Inpharma, Vol. 1, Iss. 1564, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Exploiting APC Function as a Novel Cancer Therapy

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 90-102

Bentham Science Publishers

Access to resources Recommend Favorite